February 27, 2020

Vigene Biosciences Awarded Patent for improvements...

ROCKVILLE, Md. – February 24, 2020 – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and […]
February 27, 2020

Vigene and ASC Therapeutics Announce Long-Term Str...

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development for cell and gene […]
February 27, 2020

Vigene Biosciences Opens State-Of-The-Art Headquar...

ROCKVILLE, MD – January 29, 2020 – Vigene Biosciences, Inc. (Vigene), a pioneer in the viral gene delivery space, unveils […]
February 27, 2020

Vigene Biosciences Secures Institutional Investmen...

Rockville, MD. – April 29, 2019 – Vigene Biosciences, Inc (“Vigene”) a leading provider of viral vector products and services […]
March 29, 2019

Upcoming Events

ISBioTech Spring Meeting - March 23-25
Norfolk, VA
Gene Therapy for Rare Disorders - March 30-April 2
Boston, MA
ASGCT, - May 12-15
Boston, MA
March 29, 2019

Product Launches

We now offer the newest iterations of the GCaMP family of calcium biosensors: jGCaMP7! Available as 4 variants.
March 29, 2019

Research Highlights

Read how Osbourne, et al. has used our AAV services to test the neuroprotective efficacy of a novel gene therapy construct.
March 29, 2019

Nature Article Series

We have partnered with Nature to create an article series that highlights gene therapy production strategies and technologies.
December 18, 2018

Vigene Biosciences announces partnership with Viro...

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the […]
September 18, 2018

Nature Article Series: Insect Virus Latest Ally in...

Vigene has partnered with Nature to create a four-part series of articles highlighting production strategies and technologies that are being […]